Fund Performance - Ariel Fund delivered a +3.22% return in Q4 2025, in line with Russell 2500 Value Index (+3.15%) and Russell 2000 Value Index (+3.26%) [1] - For the trailing one-year period, the Fund advanced 14.15%, outperforming Russell 2500 Value Index (+12.73%) and Russell 2000 Value Index (+12.59%) [1] - The Fund's 5- and 10-year average annual returns were +9.36% and +9.51%, respectively [1] Market Conditions - Performance attributed to resilient corporate earnings, easing inflation, and rising expectations for accommodative monetary policy [1] - Continued enthusiasm around artificial intelligence and cloud infrastructure supported markets, although gains were concentrated in a narrow group of large-cap stocks [1] Outlook and Strategy - The firm maintains a measured and cautious outlook for 2026, citing geopolitical risks, fiscal constraints, labor market dynamics, and elevated market concentration as potential volatility sources [1] - Management reaffirmed a long-term, bottom-up approach, emphasizing strong balance sheets, durable fundamentals, and valuation discipline [1] Company Highlight: Core Laboratories Inc. - Core Laboratories Inc. (NYSE:CLB) reported sequential revenue growth driven by strong global demand for its services and products [3] - The company improved operating income, margins, and EPS, while enhancing its international presence through the acquisition of Brazil-based Solintec [3] - Core Laboratories reduced leverage to a nine-year low and returned capital to shareholders through dividends and buybacks, positioning itself for long-term growth [3] - The stock had a one-month return of -15.49%, trading between $9.72 and $20.36 over the last 52 weeks, closing at approximately $16.11 on March 5, 2026, with a market capitalization of about $735.76 million [2][3]

Core Company Overview - Core Laboratories Inc. reported second quarter 2025 revenue of $130.2 million, reflecting a 5% sequential increase and flat year-over-year performance [8][30] - The company's operating income was $15.3 million, with earnings per diluted share (EPS) of $0.22, while operating income excluding items was $14.5 million, yielding operating margins of 11% [8][30] - Free cash flow for the quarter was $10.4 million, up over 160% sequentially, and the company repurchased 237,632 shares valued at $2.7 million [8][11] Segment Performance - Reservoir Description segment generated revenue of $86.3 million, up 7% sequentially and flat year-over-year, with operating income of $12.2 million [3][30] - Production Enhancement segment reported revenue of $43.9 million, a 3% sequential increase but flat year-over-year, with operating income of $3.1 million [6][30] Strategic Initiatives - Core Lab opened a new Unconventional Core Analysis Laboratory in Dammam, Saudi Arabia, enhancing its service capabilities in the Middle East [4] - The company completed a comprehensive analytical program for a major International Oil Company in the Campos Basin, Brazil, reinforcing its role as a trusted technical partner [5] Financial Health - As of June 30, 2025, Core's net debt was $94.8 million, reduced by $9.1 million during the quarter, with a leverage ratio of 1.27, the lowest in eight years [12][13] - The company renewed its credit agreement, expanding to include a $100 million revolving credit facility and a $50 million delayed draw term loan [13] Market Outlook - Despite geopolitical challenges and softer U.S. land activity, Core maintains a positive long-term outlook for international upstream activity, with forecasts for crude oil demand growth between 0.7 and 1.3 million barrels per day in 2025 [19][20] - The company anticipates that large-scale international oil and gas projects will remain less sensitive to near-term crude oil price volatility [20]

Core Insights - Core Laboratories Inc. (CLB) is expected to report first-quarter 2025 results on April 23, with a consensus estimate of 15 cents per share in profit and revenues of $124.1 million [1] Recent Performance - In the last reported quarter, CLB's adjusted earnings were 22 cents per share, missing the consensus estimate by 1 cent, primarily due to poor performance in the Production Enhancement segment [2] - Operating revenues for the last quarter were $129.2 million, which also fell short of the Zacks Consensus Estimate by 1.3% [2] - Over the trailing four quarters, CLB has beaten the consensus estimate twice, matched once, and missed once, with an average surprise of 4.79% [3] Earnings Estimates - The Zacks Consensus Estimate for first-quarter 2025 earnings has been revised downward by 11.8% in the past 30 days, indicating a 21.1% year-over-year decline [3] - Revenue estimates for the upcoming quarter also reflect a decline of 4.3% compared to the same period last year [3] Revenue Projections - Revenues are expected to decline due to weak performance in both the Reservoir Description and Production Enhancement segments [5] - Reservoir Description segment revenues are projected to decrease by 1.7% year-over-year to $82.8 million, influenced by global economic uncertainties and severe weather conditions [5] - Production Enhancement segment revenues are anticipated to drop by 8.6% year-over-year to $41.5 million, affected by freezing conditions impacting U.S. drilling activities [5] Cost Management - CLB's total operating expenses for the first quarter are expected to be $113.2 million, down 6.5% from the previous year [6] - Costs associated with services and product sales are projected to decrease from $104.6 million to $101.7 million, while general and administrative expenses are expected to decline from $11.8 million to $10.1 million [6] Earnings Prediction Model - The current model does not predict an earnings beat for CLB this season, as it lacks a positive Earnings ESP and holds a Zacks Rank of 4 (Sell) [8][9] - CLB's Earnings ESP stands at +2.27%, indicating a slight potential for earnings surprise, but overall expectations remain low [9]